Biogen
BIIB
#647
Rank
$29.60 B
Marketcap
$198.18
Share price
-2.70%
Change (1 day)
-31.59%
Change (1 year)

Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.

Biogen (BIIB) Fails to deliver data

Key failure to deliver metrics for Biogen:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Biogen (BIIB) - 3 month history

Number of shares, 3 month chart

Biweekly Failures to deliver volume for Biogen (BIIB) - since 2013

Volume in USD (price x number of shares), data since 2013

Biogen (BIIB) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024$17.64 M-68.72%
2023$56.4 M-14.65%
2022$66.08 M7.92%
2021$61.24 M-56.04%
2020$0.13 B67.82%
2019$83.01 M-43.79%
2018$0.14 B69.32%
2017$87.22 M-29.4%
2016$0.12 B-16.47%
2015$0.14 B-18.15%
2014$0.18 B579.65%
2013$26.59 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3months) FTD volume (1 year) Country
$0.14 B$0.60 B๐Ÿ‡บ๐Ÿ‡ธ USA
$36.43 M$0.32 B๐Ÿ‡บ๐Ÿ‡ธ USA
$9.89 M$0.19 B๐Ÿ‡บ๐Ÿ‡ธ USA
$54.23 M$0.21 B๐Ÿ‡บ๐Ÿ‡ธ USA
$26.04 M$54.23 M๐Ÿ‡ซ๐Ÿ‡ท France
$0.12 B$0.27 B๐Ÿ‡บ๐Ÿ‡ธ USA
$1.25 M$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
N/A$0.02 M๐Ÿ‡บ๐Ÿ‡ธ USA
$4.06 M$69.9 M๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$0.11 M$7.79 M๐Ÿ‡บ๐Ÿ‡ธ USA